Hormone EPO shown to improve brain sharpness in patients with depression and bipolar disorder
Monday, September 19, 2016 - 08:01
in Health & Medicine
A study has found that EPO (erythropoietin) – best known as a performance-enhancing drug in sport – may improve cognitive functioning in patients suffering from bipolar disorder or depression. This raises hope for the first long-term treatment for this problem, which affects hundreds of millions of patients throughout the world.